ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver transplantation"

  • 2018 American Transplant Congress

    Making Sense of Hepatitis B Reactivation Risk in Anti-HBc Antibody (Ab) Positive Liver Transplant Recipients

    S. Leistman,1 J. Melaragno,1 M. Dokus,2 B. Al-Judaibi,2 T. Babu.3

    1Department of Pharmacy, University of Rochester Medical Center, Rochester, NY; 2Division of Transplantation, University of Rochester Medical Center, Rochester, NY; 3Division of Infectious Diseases, University of Rochester Medical Center, Rochester, NY.

    Background: Limited data exists regarding the rates of reactivation of hepatitis B virus (HBV) in anti-HBc Ab positive orthotopic liver transplant (OLT) recipients. Protocols vary…
  • 2018 American Transplant Congress

    Donor Liver Apoptosis is Associated with Early Allograft Dysfunction and Short-Time Graft Survival after Liver Transplantation

    Z. Guo, Z. Zhu, Y. Tang, S. Huang, Z. Zhang, X. He, G. Chen.

    Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.

    Aims The aim of the study was to determine whether donor liver apoptosis is predictive for early allograft dysfunction (EAD) and graft survival after liver…
  • 2018 American Transplant Congress

    Living Donor Liver Transplantation for Alcoholic Liver Disease: Data from the A2ALL Study

    H. Braun, J. Dodge, J. Grab, S. Syed, G. Roll, C. Freise, J. Roberts, N. Ascher.

    Surgery, University of California, San Francisco, San Francisco, CA.

    The literature on living donor liver transplantation (LDLT) for alcoholic liver disease (ALD) is primarily from single Asian centers. We investigated LDLT outcomes for ALD…
  • 2018 American Transplant Congress

    Donor TM6SF2 rs58542926 Genotype is a Risk Factor for Liver Graft Steatosis

    I. Mikova,1 M. Neroldova,2 J. Hubacek,2 D. Dlouha,2 L. Kolesar,3 M. Jirsa,2 E. Honsova,4 E. Sticova,4 V. Lanska,5 J. Spicak,1 P. Trunecka.1

    1Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; 2Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; 3Department of Clinical and Transplant Immunology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; 4Department of Clinical and Transplant Pathology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; 5Medical Statistics Unit, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.

    Background & Aims: The rs58542926 c.449C>T (p.E167K) polymorphism in TM6SF2 (transmembrane 6 superfamily member 2) is one of genetic factors predisposing to nonalcoholic fatty liver…
  • 2018 American Transplant Congress

    Predictors of Graft Survival amongst Recipients of Liver Allografts with Prolonged Cold Ischemic Time (CIT)

    J. Steggerda,1 K. Kim,1 D. Malinoski,2 M. Bloom.1

    1Surgery, Cedars-Sinai Medical Center, Los Angeles, CA; 2Surgery, Oregon Health Science University, Portland, OR.

    Background: CIT is an independent risk factor for worse outcomes in liver transplantation (LT). Factors contributing to improved graft survival in organs with CIT ≥12…
  • 2018 American Transplant Congress

    Donor Hepatectomy Time in Donation after Circulatory Death Donors is an Independent Risk Factor for the Development of Biliary Strictures and Early Graft Loss after Transplantation

    O. van Leeuwen,1 M. van Reeven,2 M. Fujiyoshi,1 V. de Meijer,1 R. de Kleine,1 M. de Boer,1 J. de Jonge,2 J. Ijzermans,2 W. Polak,2 R. Porte.1

    1Department of Surgery, University Medical Center Groningen, Groningen, Netherlands; 2Department of Surgery, Erasmus Medical Center, Rotterdam, Netherlands.

    Introduction: Liver transplantation (LT) from donors after circulatory death (DCD) is associated with an increased risk of non-anastomotic biliary strictures (NAS) and early graft loss…
  • 2018 American Transplant Congress

    Comparative Analysis of Alloantigen-Stimulated Gene Expression in HIV(+) Liver Transplant Rejectors versus Non-Rejectors

    S. Chu, K. Lee, C. Ward, P. Stock, Q. Tang.

    Surgery, University of California, San Francisco, San Francisco, CA.

    In a multi-center, prospective trial of solid-organ transplantation in persons with HIV, recipients had a 2-3x increased rejection rate when compared to historical data on…
  • 2018 American Transplant Congress

    Early Postoperative Acute Kidney Injury among Pediatric Liver Transplant Recipients

    H. Sahinturk,1 A. Kundakci,1 P. Zeyneloglu,1 E. Gedik,1 A. Pirat,1 M. Haberal.2

    1Anesthesiology, Baskent University, Ankara, Turkey; 2Transplantation, Baskent University, Ankara, Turkey.

    Introduction: Acute kidney injury (AKI) after pediatric liver transplantation (LT) is a serious complication associated with increased morbidity and mortality. Here we evaluate children with…
  • 2018 American Transplant Congress

    Side Effect Profile of Everolimus in Liver Transplant Patients

    F. Kumssa, O. Sadiq, M. Alimirah, R. Kaur, A. Patel, S-.M. Jafri.

    Henry Ford Hospital, Detroit.

    IntroductionUse of calcineurin inhibitors has been the mainstay of antirejection medications after liver transplant (LT). However, renal toxicity from these drugs remains troublesome. By comparison,…
  • 2018 American Transplant Congress

    Pragmatic Surgical Risk Assessment Criteria in Critically Ill Patients Prior to Liver Transplantation

    C. Bonham, Z. Tulu, M. Melcher, P. Kwo, W. Concepcion, A. Ahmed, C. Esquivel.

    Liver Transplant Program, Stanford University School of Medicine, Stanford, CA.

    Futility rules in critically ill patients awaiting liver transplantation (LT) are lacking in this era of severe organ shortage of organs. We aim to identify…
  • « Previous Page
  • 1
  • …
  • 103
  • 104
  • 105
  • 106
  • 107
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences